IL10 and colorectal cancer: Indeed, using organotypic cell culture approaches, Sullivan and colleagues found that IL-10 blockade potentiates anti-tumor T cell responses and decreases the percentage of exhausted CD8+ T cells in human colorectal cancer liver metastases.